Ashish M. Kamat

A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer

David J. McConkey, Woonyoung Choi, Yu Shen et al. · European Urology · 2015 · 277 citations · Full text

Medicine, Oncology, Pharmacology +15

Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy

Stephen H. Culp, Rian J. Dickstein, H. Barton Grossman et al. · The Journal of Urology · 2013 · 177 citations · Full text

Medicine, Oncology, Surgery +11

Genome-wide association study identifies multiple loci associated with bladder cancer risk

Jonine D. Figueroa, Yuanqing Ye, Afshan Siddiq et al. · Human Molecular Genetics · 2013 · 161 citations · Full text

Life Sciences, Genetics, Oncology +17

Clinical Outcomes of cT1 Micropapillary Bladder Cancer

Daniel Willis, Mario I. Fernández, Rian J. Dickstein et al. · The Journal of Urology · 2014 · 131 citations · Full text

Medicine, Oncology, Urology +13

Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity

Ashish M. Kamat, José A. Karam, H. Barton Grossman et al. · British Journal of Urology · 2011 · 71 citations

Medicine, Oncology, Urology +16